Investments in and Advances to Joint Ventures (Tables)

9 Months Ended

Sep. 30, 2021

Equity Method Investments And Joint Ventures [Abstract]

Schedule of Financial Information of Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

	September 30, 2021		December 31, 2020
Current assets	$	253,105	$	292,407
Noncurrent assets		1,856		2,990
Total assets		254,961		295,397
Current liabilities		194,543		201,270
Total liabilities		194,543		201,270
Total joint venture equity	$	60,418	$	94,127

	Three Months Ended				Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Revenue	$	101,816	$	117,344	$	296,685	$	335,511
Costs		86,726		105,223		260,129		304,308
Net income	$	15,090	$	12,121	$	36,556	$	31,203
Net income attributable to noncontrolling interests	$	7,411	$	5,862	$	17,711	$	15,086

Summary of Financial Information for Unconsolidated Joint Ventures

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

	September 30, 2021		December 31, 2020
Current assets	$	1,103,345	$	774,646
Noncurrent assets		554,366		585,802
Total assets		1,657,711		1,360,448
Current liabilities		789,072		703,287
Noncurrent liabilities		562,523		517,697
Total liabilities		1,351,595		1,220,984
Total joint venture equity	$	306,116	$	139,464
Investments in and advances to unconsolidated joint ventures	$	102,677	$	68,975

	Three Months Ended				Nine Months Ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Revenue	$	728,461	$	594,640	$	1,701,262	$	1,286,087
Costs		697,493		551,624		1,604,538		1,202,315
Net income	$	30,968	$	43,016	$	96,724	$	83,772
Equity in earnings of unconsolidated joint ventures	$	9,570	$	16,741	$	26,528	$	26,624